Subclassifications Of Assets, Liabilities And Equities [Abstract]

Ascelia Pharma - Filing #678716

Concept	As at 2023-12-31	As at 2022-12-31	As at 2021-12-31
Subclassifications of assets, liabilities and equities [abstract]
Property, plant and equipment [abstract]
Property, plant and equipment	89,000 SEK	163,000 SEK	—
Intangible assets and goodwill [abstract]
Intangible assets other than goodwill [abstract]
Intangible assets other than goodwill	57 074 SEK	57 074 SEK	—
Trade and other current receivables [abstract]
Current prepayments and current accrued income other than current contract assets [abstract]
Current prepayments [abstract]
Current advances to suppliers	3 433 SEK	5 359 SEK	—
Other current receivables	480,000 SEK	1 745 SEK	—
Current prepayments and current accrued income including current contract assets [abstract]
Current prepayments and current accrued income including current contract assets	1 188 SEK	1 426 SEK	—
Cash and cash equivalents [abstract]
Cash and cash equivalents	21 855 SEK	149 555 SEK	261 599 SEK
Trade and other current payables [abstract]
Current trade payables	1 525 SEK	15 881 SEK	—
Current accruals and current deferred income including current contract liabilities [abstract]
Current accruals and current deferred income including current contract liabilities	8 519 SEK	19 657 SEK	—
Miscellaneous current liabilities [abstract]
Other current liabilities	1 640 SEK	1 688 SEK	—
Issued capital [abstract]
Issued capital	34 871 SEK	34 871 SEK	—
Retained earnings [abstract]
Retained earnings	639 962 SEK	533 732 SEK	—
Accumulated other comprehensive income [abstract]
Reserve of exchange differences on translation	671,000 SEK	972,000 SEK	—
Miscellaneous equity [abstract]
Additional paid-in capital	678 747 SEK	678 747 SEK	—
Net assets (liabilities) [abstract]
Assets	87 072 SEK	218 569 SEK	—
Liabilities	12 744 SEK	37 711 SEK	—
Net current assets (liabilities) [abstract]
Current assets	28 937 SEK	160 869 SEK	—
Current liabilities	12 568 SEK	37 518 SEK	—
Assets less current liabilities [abstract]